𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lesions of the adrenal glands of rabbits caused by infection with herpes virus

✍ Scribed by Smith, Wilson

Publisher
Wiley (John Wiley & Sons)
Year
1931
Tongue
English
Weight
828 KB
Volume
34
Category
Article
ISSN
0368-3494

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pseudotumour of the tongue caused by her
Pseudotumour of the tongue caused by herpes simplex virus type 2 in an HIV-1 infected immunosuppressed patient
✍ Husak; Tebbe; Goerdt; WΓ–lfer; Zeichardt; STΓ–ffler-Meilicke; Orfanos πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 300 KB

An HIV-1 infected immunosuppressed patient (CD4+ cell counts: 382 cells/microL; viral load 94,000 copies/mL) with recurrent perianal herpes simplex virus type 2 (HSV-2) infections is described, showing an unusual exophytic tumour resembling a squamous cell carcinoma in the lateral part of the tongue

Utility of fine-needle aspiration in the
Utility of fine-needle aspiration in the diagnosis of salivary gland lesions in patients infected with human immunodeficiency virus
✍ David C. Chhieng; Ryan Argosino; Barbara J. McKenna; Joan F. Cangiarella; Jean-M πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 2 views

Fine-needle aspiration (FNA) has been increasingly utilized as a diagnostic tool in evaluating salivary gland masses, primarily to differentiate nonneoplastic from neoplastic lesions. Patients infected with human immunodeficiency virus (HIV) frequently present with salivary gland lesions. In this st

Successful treatment of aciclovir and fo
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1
✍ Anne-Sophie Lascaux; Eric Caumes; Claire Deback; Giovanna Melica; Dominique Chal πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

## Abstract Aciclovir (ACV)‐resistant __Herpes simplex virus__ type‐2 (HSV‐2) infections are observed commonly in patients also infected with HIV‐1. The use of foscarnet (FOS) in these patients may also lead to resistance. This situation can become a difficult therapeutic challenge. Four cases of p